Bararu Bojan Bararu Iris, Pleșoianu Carmen Elena, Badulescu Oana Viola, Vladeanu Maria Cristina, Badescu Minerva Codruta, Iliescu Dan, Bojan Andrei, Ciocoiu Manuela
Department of Pathophysiology, Morpho-Functional Sciences, Faculty of Medicine, 'Grigore T. Popa' University of Medicine and Pharmacy, 16 Unirii Street, 700115 Iași, Romania.
Department of Internal Medicine, Faculty of Medicine, 'Grigore T. Popa' University of Medicine and Pharmacy, 700115 Iași, Romania.
Diagnostics (Basel). 2023 Jan 10;13(2):253. doi: 10.3390/diagnostics13020253.
Aortic aneurysms represent a very common pathology that can affect any segment of the aorta. These types of aneurysms can be localized on the thoracic segment or on the abdominal portion, with the latter being more frequent. Though there are similarities between thoracic and abdominal aortic aneurysms, these pathologies are distinct entities. In this article, we undertook a review regarding the different mechanisms that can lead to the development of aortic aneurysm, and we tried to identify the different manners of treatment. For a long time, aortic wall aneurysms may evolve in an asymptomatic manner, but this progressive dilatation of the aneurysm can lead to a potentially fatal complication consisting in aortic rupture. Because there are limited therapies that may delay or prevent the development of acute aortic syndromes, surgical management remains the most common manner of treatment. Even though, surgical management has improved much in the last years, thus becoming less invasive and sophisticated, the morbi-mortality linked to these therapies remains increased. The identification of the cellular and molecular networks triggering the formation of aneurysm would permit the discovery of modern therapeutic targets. Molecular and cellular mechanisms are gaining a bigger importance in the complex pathogenesis of aortic aneurysms. Future studies must be developed to compare the findings seen in human tissue and animal models of aortic aneurysm, so that clinically relevant conclusions about the aortic aneurysm formation and the pharmacological possibility of pathogenic pathways blockage can be drawn.
主动脉瘤是一种非常常见的病理状况,可累及主动脉的任何节段。这类动脉瘤可局限于胸段或腹段,其中腹段更为常见。尽管胸主动脉瘤和腹主动脉瘤之间存在相似之处,但这些病理状况是不同的实体。在本文中,我们对可导致主动脉瘤形成的不同机制进行了综述,并试图确定不同的治疗方式。长期以来,主动脉壁动脉瘤可能以无症状的方式发展,但这种动脉瘤的渐进性扩张可导致一种潜在致命的并发症,即主动脉破裂。由于能够延迟或预防急性主动脉综合征发生的治疗方法有限,手术治疗仍然是最常见的治疗方式。尽管近年来手术治疗有了很大改进,变得创伤更小、技术更复杂,但与这些治疗相关的病残率和死亡率仍然很高。识别引发动脉瘤形成的细胞和分子网络将有助于发现现代治疗靶点。分子和细胞机制在主动脉瘤复杂的发病机制中变得越来越重要。必须开展进一步研究,以比较在人体组织和主动脉瘤动物模型中观察到的结果,从而得出关于主动脉瘤形成以及阻断致病途径的药理学可能性的临床相关结论。